Biotech
Star Therapeutics
Star Therapeutics raises $125M Series C at $650M valuation
Cambridge, MAOctober 3, 20251 min read
Total Raised
$125M
Valuation
$650M
Latest Round
Series C
Employees
95+
Star Therapeutics: Series C Funding Round
Star Therapeutics has successfully raised $125M in Series C funding, reaching a valuation of $650M.
Company Overview
Cell therapy platform for cancer treatment
Funding Details
The Series C round was led by RA Capital, with participation from Arch Venture Partners.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2020
- Employees: 95+
- Category: Biotech
Investment
Star Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- RA Capital: Verified investor in Series C
- Arch Venture Partners: Verified investor in Series C
Company Info
Headquarters
Cambridge, MA
Founded
2020
Team Size
95+
Last Round
$125M(Oct 2025)
Investors (2)
R
RA CapitalLeadLead Investor
Verified investor in Series C
A
Arch Venture PartnersInvestor
Verified investor in Series C
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free